Belt and Road Summit 2025- Deal-making

10–16 Sept 2025 | China (Hong Kong)

Register
Register
Register

ProjectUpdated on 7 August 2025

The first company in China to hold Class II & III of registration certificates for both dental implants and personalized abutments

Nick Yip

Senior Manager at Guangdong Cas Angels Biotechology CO., LTD 广东中科安齿生物科技有限公司

Hong Kong, China (Hong Kong)

About

广东中科安齿生物科技有限公司(简称“中科安齿”)是由中科院孵化的一家具有国家二类、三类医疗器械资质的省级专精特新企业,是中国首家同时拥有牙种植体和个性化基台三类注册证的企业,2023年,成为广东省唯一入选国家集采的本土企业,是甲类中标单位;2024年,与国家一级央企通用技术宝石花医疗签署全面战略合作协议,成为其国产医疗器械的独家供应商。

公司产品已获准4个三类、多个二类国家医疗器械注册证。目前已获得知名股权投资机构的八轮风险投资,是上市科创板的后备50家企业之一。

公司主要研发如下产品及技术:

(1)达到世界一流水平的通用型牙科种植体;

(2)基于影像技术和3D打印技术的个性化牙科种植体;

(3)研发个性化牙科骨粉用支撑钛网,为大面积骨缺损情况下的口腔种植手术提供引导骨再生的新治疗方案;

(4)微米-纳米复合亲水性表面处理技术,并以此建造自主知识产权的医疗器械表面处理生产线;

(5)提供基于扫描,影像等技术,以修复为导向、以精准为核心,自动匹配最优种植方案的数字化种植技术,以应对各种口腔种植疑难杂症;

(6)把3D打印相关技术融入癌症修复、创伤救治和整容整形等诸多领域,开发个性化精准医疗修复材料;

(7)开发基于口腔检查的人工智能健康护航系统,由硬件、软件及应用平台三部分组成,通过AI技术对口腔健康数据进行深入分析,做出健
康管理;

We are actively seeking potential partners to expand our sales channels, including distributors worldwide, as well as public and private hospitals. We are also open to exploring joint venture opportunities.

CAS Angel Biotechnology Co., Ltd. (广东中科安齿生物科技有限公司, abbreviated as “CAS Angel”) is a provincial-level “Specialized, Refined, Differentiated, and Innovative” enterprise incubated by the Chinese Academy of Sciences (CAS). The company holds national qualifications for both Class II and Class III medical devices, and is the first enterprise in China to simultaneously obtain Class III registration certificates for dental implants and customized abutments.

To date, the company has obtained four Class III and multiple Class II national medical device registration certificates. CAS Angel has completed eight rounds of venture capital financing from prominent investment institutions and is listed as one of the Top 50 reserve enterprises for a STAR Market IPO.

CAS Angel focuses on the research and development of the following core products and technologies:

  1. World-class universal dental implants

  2. Customized dental implants based on imaging technology and 3D printing

  3. Titanium mesh supports for personalized dental bone grafting materials, providing new guided bone regeneration (GBR) solutions for large-area bone defects during oral implant surgeries

  4. Micron-nano composite hydrophilic surface treatment technology, and the development of a self-owned IP production line for surface treatment of medical devices

  5. Digital implantology solutions based on scanning and imaging, which are restoration-oriented and precision-driven, capable of automatically matching optimal implant strategies for various complex cases

  6. Integration of 3D printing technologies into cancer reconstruction, trauma recovery, and cosmetic surgery, to develop personalized precision medical restoration materials

  7. An AI-based oral health monitoring system, comprising hardware, software, and an application platform, which uses artificial intelligence to analyze oral health data and provide intelligent health management services

Project Location

  • China

Project Format

  • Private Project

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Project Planning

Main Project Sector

  • Manufacturing

Technology

  • Bio-Tech

Interested Format of Cooperation

  • 100% Takeover
  • Equal Shareholdings
  • Joint Venture
  • Majority Shareholdings
  • Minority Shareholdings
  • Open for Negotiation
  • Public–private partnership / Concession
  • R&D Cooperation

Preferred Financing Model

  • Debt
  • Equity
  • Open for negotiation

Previous Funding Stage

  • Series C and beyond

Main Service(s) Required

  • Financial Services
  • Professional Services

Similar opportunities

  • Investment

    WarrenT 跨境技术价值挖掘引擎

    • Technology
    • Middle East
    • South-East Asia
    • Seed & Pre-Series

    Yuan Wang

    创始人CEO at WarrenT AI

    深圳, China

  • Project

    跨境技术价值挖掘引擎

    • No
    • None
    • Equity
    • Fin-Tech
    • Technology
    • Private Project
    • Big Data Solution
    • Financial Services
    • Industry Solutions
    • Corporate Services
    • Open for Negotiation
    • Open for negotiation
    • Enterprise Solutions
    • Minority Shareholdings
    • Corporate Intelligence
    • Requisition of Service
    • 500,001 to 1,000,000 USD
    • Feasibility Study Completed
    • Private Equity & Venture Capital

    Yuan Wang

    创始人CEO at WarrenT AI

    深圳, China

  • Service

    跨境技术价值挖掘引擎

    • Middle East
    • Mainland China
    • South-East Asia
    • Big Data Solution
    • Internet Services
    • Financial Services
    • Investment Banking
    • Industry Solutions
    • Corporate Services
    • Enterprise Solutions
    • Advisory & Consultancy
    • Corporate Intelligence
    • Institutional Investment
    • Private Equity & Venture Capital

    Yuan Wang

    创始人CEO at WarrenT AI

    深圳, China